Racial/Ethnic Disparities in Influenza Vaccination Coverage Among US Adolescents, 2010-2016.

Racial/Ethnic Disparities in Influenza Vaccination Coverage Among US Adolescents, 2010-2016. Public Health Rep. 2018 Oct 09;:33354918805720 Authors: Webb NS, Dowd-Arrow B, Taylor MG, Burdette AM Abstract OBJECTIVE: Although research suggests racial/ethnic disparities in influenza vaccination and mortality rates, few studies have examined racial/ethnic trends among US adolescents. We used national cross-sectional data to determine (1) trends in influenza vaccination rates among non-Hispanic white (hereinafter, white), non-Hispanic black (hereinafter, black), and Hispanic adolescents over time and (2) whether influenza vaccination rates among adolescents varied by race/ethnicity. METHODS: We analyzed provider-reported vaccination histories for 2010-2016 from the National Immunization Survey-Teen. We used binary logistic regression models to determine trends in influenza vaccination rates by race/ethnicity for 117 273 adolescents, adjusted for sex, age, health insurance, physician visit in the previous 12 months, vaccination facility type, poverty status, maternal education level, children in the household, maternal marital status, maternal age, and census region of residence. We calculated adjusted probabilities for influenza vaccination for each racial/ethnic group, adjusted for the same demographic characteristics. RESULTS: Compared with white adolescents, Hispanic adolescents had higher odds (adjusted odds ratio [aOR] = 1.11; 95% confidenc...
Source: Public Health Reports - Category: International Medicine & Public Health Tags: Public Health Rep Source Type: research

Related Links:

Preliminary estimates show influenza vaccine effectiveness for 2019-2020 was 55% in children and 45% overall, according to the Centers for Disease Control and Prevention.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
TTP, a technology company based in Melbourn, UK, is developing a handheld PCR (polymerase chain reaction) diagnostic device that can rapidly detect influenza viruses, and one day other viruses, in samples of nasal mucus. The company claims that the s...
Source: Medgadget - Category: Medical Devices Authors: Tags: Diagnostics Exclusive Public Health Source Type: blogs
THURSDAY, Feb. 20, 2020 -- The overall vaccine effectiveness (VE) against any influenza virus associated with medically attended acute respiratory illness (ARI) is 45 percent for the current influenza season, according to research published in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
(NEW YORK) — It may end up being a bad flu season for kids, but early signs suggest the vaccine is working OK. The vaccine has been more than 50% effective in preventing flu illness severe enough to send a child to the doctor’s office, the U.S. Centers for Disease Control and Prevention said Thursday. Health experts consider that pretty good. The vaccines are made each year to protect against three or four different kinds of flu virus. The ingredients are based on predictions of what strains will make people sick the following winter. It doesn’t always work out. This flu season has featured two waves, ea...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized influenza onetime Source Type: news
CDC preliminary vaccine effectiveness estimates show 2019-20 influenza vaccines providing substantial protective benefit, particularly among children, who have been hard hit by influenza this season. Influenza vaccines are reducing the risk for having to go to the doctor with influenza illness by 45% overall and by 55% in children.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Children's Health Influenza (Flu) MMWR Morbidity & Mortality Weekly Report Vaccines Source Type: news
Review (6 cohort studies, n=179,158) found influenza vaccination was associated with a lower risk of all-cause mortality (HR=0.83; 95%CI 0.76 to 0.91; I2=75%). However, evidence statements are based on very low grade quality evidence.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
.
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research
Alzheimer ’s disease (AD) is a neurodegenerative disorder strongly correlated with a dysfunctional immune system. Our previous results demonstrated that inactivated influenza vaccine (IIV) facilitates hippocamp...
Source: Journal of Neuroinflammation - Category: Neurology Authors: Tags: Research Source Type: research
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020. The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors. The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
by Lauren A. Castro, Trevor Bedford, Lauren Ancel Meyers Influenza A/H3N2 is a rapidly evolving virus which experiences major antigenic transitions every two to eight years. Anticipating the timing and outcome of transitions is critical to developing effective seasonal influenza vaccines. Using a published phylodynamic model of influenza transmission, w e identified indicators of future evolutionary success for an emerging antigenic cluster and quantified fundamental trade-offs in our ability to make such predictions. The eventual fate of a new cluster depends on its initial epidemiological growth rate––which ...
Source: PLoS Computational Biology - Category: Biology Authors: Source Type: research
More News: Children | Education | Health Insurance | Influenza | Influenza Vaccine | Insurance | International Medicine & Public Health | Study | Universities & Medical Training | Vaccines